Literature DB >> 9668357

Gangliosides and sialylcholesterol as modulators of synaptic functions.

S Ando1, Y Tanaka, H Waki, K Kon, M Iwamoto, F Fukui.   

Abstract

Gangliosides were shown to enhance the release of acetylcholine from synaptosomes on stimulation. The influx of calcium ion into synaptosomes on membrane depolarization was increased by gangliosides. This was hypothesized to be an underlying mechanisms for the enhancement of acetylcholine release. Studies using calcium channel blockers revealed that four distinct types of voltage-dependent calcium channels occurred in cerebrocortical synapses, and that the N-type was primarily responsible for the evoked release of acetylcholine. An additional result suggests that gangliosides may act mainly on the N-type calcium channel. Cholinergic-specific gangliosides, Chol-1 alpha, were assumed to participate in the mechanism of high-affinity choline uptake. These two different actions of gangliosides were found to be mimicked by synthetic ganglioside analogs. Calcium influx was increased by alpha-sialylcholesterol, and choline uptake was accelerated by beta-sialylcholesterol. Gangliosides and sialylcholesterol having these apparently beneficial effects were shown to ameliorate decreased functions of synapses from aged brains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668357     DOI: 10.1111/j.1749-6632.1998.tb09676.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

1.  Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

2.  Exogenous gangliosides increase the release of brain-derived neurotrophic factor.

Authors:  Seung T Lim; Kamilla Esfahani; Valeriya Avdoshina; Italo Mocchetti
Journal:  Neuropharmacology       Date:  2010-10-28       Impact factor: 5.250

Review 3.  Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.

Authors:  Jaap J Plomp; Hugh J Willison
Journal:  J Physiol       Date:  2009-06-29       Impact factor: 5.182

4.  Rapid regulation of sialidase activity in response to neural activity and sialic acid removal during memory processing in rat hippocampus.

Authors:  Akira Minami; Yuko Meguro; Sayaka Ishibashi; Ami Ishii; Mako Shiratori; Saki Sai; Yuuki Horii; Hirotaka Shimizu; Hokuto Fukumoto; Sumika Shimba; Risa Taguchi; Tadanobu Takahashi; Tadamune Otsubo; Kiyoshi Ikeda; Takashi Suzuki
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 5.  Gangliosides in Nerve Cell Specification.

Authors:  Yutaka Itokazu; Jing Wang; Robert K Yu
Journal:  Prog Mol Biol Transl Sci       Date:  2018-01-17       Impact factor: 3.622

6.  Effects of gangliosides on the activity of the plasma membrane Ca2+-ATPase.

Authors:  Lei Jiang; Misty D Bechtel; Jennifer L Bean; Robert Winefield; Todd D Williams; Asma Zaidi; Elias K Michaelis; Mary L Michaelis
Journal:  Biochim Biophys Acta       Date:  2014-01-14

7.  Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

Authors:  Roland W M Bullens; Graham M O'Hanlon; Eric Wagner; Peter C Molenaar; Keiko Furukawa; Koichi Furukawa; Jaap J Plomp; Hugh J Willison
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

8.  Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.

Authors:  Toshio Ariga; Makoto Yanagisawa; Chandramohan Wakade; Susumu Ando; Jerry J Buccafusco; Michael P McDonald; Robert K Yu
Journal:  ASN Neuro       Date:  2010-10-04       Impact factor: 4.146

Review 9.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

10.  Cav2.1 voltage-dependent Ca2+ channel current is inhibited by serum from select patients with Guillain-Barré syndrome.

Authors:  Yoshihiko Nakatani; Sayako Hotta; Iku Utsunomiya; Keiko Tanaka; Keiko Hoshi; Toshi Ariga; Robert K Yu; Tadashi Miyatake; Kyoji Taguchi
Journal:  Neurochem Res       Date:  2008-05-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.